These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 3953770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Study on correlation between aminonucleoside induced experimental focal glomerular sclerosis and mesangial dysfunction in rats (author's transl)].
    Sawaguchi H.
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):109-24. PubMed ID: 7098139
    [No Abstract] [Full Text] [Related]

  • 3. The enhancement of aminonucleoside nephrosis by the co-administration of protamine.
    Saito T, Sumithran E, Glasgow EF, Atkins RC.
    Kidney Int; 1987 Nov; 32(5):691-9. PubMed ID: 3323599
    [Abstract] [Full Text] [Related]

  • 4. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experimental focal segmental glomerulosclerosis: correlation with protein excretion, glomerular filtration rate, and renal plasma flow.
    Chandra M, Susin M, Teichberg S, McVicar M.
    Pediatr Res; 1984 Nov; 18(11):1195-201. PubMed ID: 6514447
    [Abstract] [Full Text] [Related]

  • 10. Persistent nephrotic syndrome and focal glomerular sclerosis produced in rats by aminonucleoside and protamine.
    Saito T, Yamakage K, Furuyama T, Yoshinaga K.
    Tohoku J Exp Med; 1982 Sep; 138(1):117-8. PubMed ID: 7147231
    [No Abstract] [Full Text] [Related]

  • 11. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J, Muller EW, van Goor H, Weening JJ, Elema JD.
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [An ultrastructural study on experimental focal glomerular sclerosis].
    Sano M, Terasaki T, Narita M, Tojo S.
    Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1345-54. PubMed ID: 6527434
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.
    Elema JD, Weening JJ, Grond J.
    Contrib Nephrol; 1988 Oct; 60():73-82. PubMed ID: 3278860
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T, Morohoshi T.
    Nephron; 1992 May; 60(4):443-7. PubMed ID: 1584321
    [Abstract] [Full Text] [Related]

  • 19. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.
    Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605
    [Abstract] [Full Text] [Related]

  • 20. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    Ren Physiol; 1986 Feb 15; 9(6):366-74. PubMed ID: 3602582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.